Rule of thumb: A simple tool to estimate 1% scalp surface area - 27/07/19
Doi : 10.1016/j.jaad.2019.01.022
Carlos Gustavo Wambier, MD, PhD ⁎ 
, Brett A. King, MD, PhD
, Brett A. King, MD, PhD Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut
∗Reprint requests: Carlos Gustavo Wambier, MD, PhD, Yale Center for Clinical Investigation, 2 Church St South, Ste 401, New Haven, CT, 06519Yale Center for Clinical Investigation2 Church St South, Ste 401New HavenCT06519
Graphical abstract |
| Funding sources: Supported by The Ranjini and Ajay Poddar Resource Fund for dermatologic disease research (to Dr King). |
|
| Conflicts of interest: Dr Wambier is an investigator in alopecia areata clinical trials for Concert Pharmaceuticals Inc, Eli Lilly and Company, and Pfizer Inc. Dr King is a consultant for Aclaris Therapeutics Inc, Eli Lilly and Company, Concert Pharmaceuticals Inc, Pfizer Inc, and Dermavant Sciences Inc; has served on advisory boards for Eli Lilly and Company, Dermavant Sciences Inc, and Pfizer Inc; and is a clinical trial investigator in alopecia areata clinical trials for Concert Pharmaceuticals Inc, Eli Lilly and Company, and Pfizer Inc. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 81 - N° 2
P. 630-631 - août 2019 Retour au numéro
Article précédent
- Impact of dermatology consultation on the care of children with chronic graft-versus-host disease of the skin
- Anna Cristina Garza-Mayers, L. Elizabeth Anderson, JiaDe Yu, Jennifer T. Huang
- Impact of the Patient Protection and Affordable Care Act on dermatologic health care utilization
- Raghav Tripathi, Konrad D. Knusel, Harib H. Ezaldein, Jeremy S. Bordeaux, Jeffrey F. Scott
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?